Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells

• Hyun Don Yun,
• Martin Felices,
• Daniel A. Vallera,
• Peter Hinderlie,
• Sarah Cooley,
• Michel Arock,
• Jason Gotlib,
• Celalettin Ustun,
• Jeffrey S. Miller

Affiliations

Hyun Don Yun

Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN;

Martin Felices

Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN;

Daniel A. Vallera

Department of Therapeutic Radiology–Radiation Oncology, University of Minnesota, Minneapolis, MN;

Peter Hinderlie

Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN;

Sarah Cooley

Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN;

Michel Arock

Cellular and Molecular Oncology, Laboratoire de Biologie et Pharmacologie Appliquée, Centre National de la Recherche Scientifique Unité Mixte de Recherche 8113, Ecole Normale Supérieure de Paris-Saclay, Cachan, France;; Laboratory of Hematology, Pitié-Salpêtrière Hospital, Paris, France;

Jason Gotlib

Division of Hematology, Stanford Cancer Institute, Stanford University, Palo Alto, CA

Celalettin Ustun

Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN;

Jeffrey S. Miller

Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN;; Jeffrey S. Miller, Division of Hematology, Oncology, and Transplantation, University of Minnesota, 420 Delaware St SE, Mayo Mail Code 806, Minneapolis, MN 55455;